descriptionPublicationkeyboard_double_arrow_right Article 01 May 2004 English Publisher:BMJJournal:British Journal of Ophthalmology, volume 88, pages 708-713 (issn: 0007-1161,

Authors: Azuara-Blanco, A.; Tomida, I.; Perlwee, R.G.;

doi: 10.1136/bjo.2003.032250

pmid: 15090428

pmc: PMC1772142

Cannabinoids and glaucoma

- Summary
- Subjects
- Metrics

Abstract

Glaucoma is one of the leading causes of blindness in the world. In spite of the diverse therapeutic possibilities, new and better treatments for glaucoma are highly desirable. Cannabinoids effectively lower the intraocular pressure (IOP) and have neuroprotective actions. Thus, they could potentially be useful in the treatment of glaucoma. The purpose of this article is to provide the reader with an overview of the latest achievements in research into the potential use of cannabinoids for glaucoma.

Related Organizations

Queen's University Belfast
United Kingdom
University of Aberdeen
United Kingdom
NHS Grampian
United Kingdom
Aberdeen Royal Infirmary
United Kingdom

Keywords

Cannabinoids, Plant Extracts, 610, Humans, Glaucoma, Ophthalmic Solutions, Phytotherapy

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	131
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%